U.S. Markets open in 44 mins

Mersana CEO details path forward after breakup with Takeda

Allison DeAngelis
Mersana CEO details path forward after breakup with Takeda

Mersana executives discussed data from its ovarian and lung cancer drug trial Wednesday. The biotech also plans to disclose its next clinical candidate in the second half of 2019.